We perform the Subvisible particles testing according to Chapters <788> and <787> of the United States Pharmacopeia (USP), Particulate Matter in Injections, and chapter 2.9.19 of the European Pharmacopoeia. We can test small- and large-volume parenteral products, particularly ready-to-use solutions for intramuscular, subcutaneous or intravenous injection.

Our laboratory is equipped with and suitable instrumentation for Light obscuration particle count test (Method 1) and Microscopic particle count test (Method 2).